The first, Loperamide Hydrochloride tablet, is used to control symptoms of diarrhoea, including travelers' diarrhoea. The approved product has an estimated market size of $9.7 million for the 12 months ending October 2015, according to IMS Health.
The other, Methylprednisolone Sodium Succinate injection, is a lyophilised product used in the treatment of various medical conditions such as allergic states and disorders. The approved product - USP 40 mg/vial, 125 mg/vial, 500 mg/vial, and 2 g/vial - has an estimated market size of $102 million for the 12 months ending October 2015, as per IMS Health.
Aurobindo now has a total of 224 Abbreviated New Drug Application (ANDA) approvals (196 final approvals, including 10 from Aurolife Pharma LLC and 28 tentative approvals) from USFDA.
Thank you for visiting my blog , Visit again for latest pharma updates.
No comments:
Post a Comment